INDUSTRIALBIOTECH-CONF-2022

27th World Congress on Industrial Biotechnology

 


The organising team extends its warmest greetings!

Following the tremendous success of the 27th World Congress on Industrial Biotechnology, we are delighted to extend an invitation to all eminent scientists, young researchers, academicians, business delegates, previous congress attendees, and students from all over the world to attend the 27th World Congress on Industrial Biotechnology, which will be held November 16-17, 2022 in Tokyo, Japan.

It is an international gathering to present and discuss advances in Industrial Biotechnology-based research, techniques, frameworks, innovations, standards, and applications of themes linked to the field. The congress will undoubtedly benefit scholars and practitioners in this field. The conference will feature a number of illustrious speakers who will present their most recent research findings that will transform the field of industrial biotechnology in the future.

Industrial Biotechnology2022 has been developed in an integrative manner, with a large number of tracks to choose from in each section, and offers you a unique opportunity to form a scientific network between academics and industry.

The two-day Industrial Biotechnology conference will feature a greater number of talks and sub-sessions on cutting-edge research in the field of Industrial Biotechnology from across the world.

Complete seminars and panel discussions on the most recent discoveries in Industrial Biotechnology will be available to attendees.

   Lectures from speakers:

•             Keynote forums by Prominent Professors, Doctors

•             Open Innovation Challenges

•              Poster presentations by Young Researchers

•              Global Networking sessions with 50+ Countries

•              Novel techniques to benefit your research

•              Best stage for business globalizing and networking opportunities

•         Interacting with editors of referred journals, different Societies and Association members across the Globe

•            Excellent platform to display the latest products and formulations in Pharmaceutics.


Visit for more details: https://industrialbiotech.conferenceseries.com/



Comments

Post a Comment

Popular posts from this blog

Industrial Biotechnology Conference 2022

Image
  Opportunities for Spaceflight to Advance Stem Cell Science, Biomanufacturing, and Disease Modeling The secret to producing large batches of stem cells more efficiently may lie in the near-zero gravity conditions of space. Scientists at Cedars-Sinai report that microgravity has the potential to contribute to life-saving advances on Earth by facilitating the rapid mass production of stem cells. A paper (“Biomanufacturing in low Earth orbit for regenerative medicine”), led by the Cedars Sinai team and published in  Stem Cell Reports , highlights key opportunities discussed during the 2020 Biomanufacturing in Space Symposium, to expand the manufacture of stem cells in space. Attendees at the virtual space symposium in December identified more than 50 potential commercial opportunities for conducting biomanufacturing work in space, according to the Cedars-Sinai paper. The most promising fell into three categories: disease modeling, biofabrication, and stem-cell–derived products. The newl
Read more

Industrial Biotech Conference 2022

Image
                  Tips for Increasing Transfection Efficiency Chemical transfection , which relies on the formation of a condensed complex of positively charged  liposomal or non-liposomal  reagents and negatively charged nucleic acids, is the most common method for delivering foreign genetic material into cultured cells. Complexes are attracted to the negatively charged cell membrane and potentially pass through it via mechanisms involving endocytosis and phagocytosis. 1 “The negative to positive ratio impacts the complex size and the overall positive charge. The best ratio is cell type dependent,” says  Sandy Tseng, PhD,   technical support scientist, Mirus Bio. Chemical methods offer a slew of advantages: relatively low cytotoxicity, ease of use, cost effectiveness, low likelihood for unintended mutagenesis , no viral vector involvement, no discrimination of type of nucleic acid, and researcher safety. But the correct protocol needs to be identified and optimized to maximize transfe
Read more

Molecular Biology Conference

Image
  A novel COVID-19 vaccine using modified bacterial DNA Experimental vaccine based on altered plasmid DNA produced antibody response in mice that effectively blocked cell infection across all variants of concern tested. Researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods. Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods. Their findings publish in the July 21, 2022 online issue of  PLOS Pathogens . The research involved building plasmids genetically altered to contain bits of genetic material specifically intended to target a vulnerability in the SARS-CoV-2 virus's spi
Read more